You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TAA

Showing 1 - 25 of 151
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Houston (TAA-specific CTLs, TAA-specific CTLs- fixed dose)

Recruiting
  • Multiple Myeloma
  • TAA-specific CTLs
  • TAA-specific CTLs- fixed dose
  • Houston, Texas
    Houston Methodist Hospital
Nov 11, 2022

Ankura™ TAA Stent Graft System Post-Market Clinical Follow-up

Not yet recruiting
  • Aneurysm Thoracic
  • Dissection of Thoracic Aorta
  • Ankura™ TAA Stent Graft Systems
  • Mendoza, Argentina
  • +7 more
Dec 5, 2022

Hodgkins Lymphoma, Non Hodgkins Lymphoma Trial in Houston (TAA-specific CTLs)

Recruiting
  • Hodgkins Lymphoma
  • Non Hodgkins Lymphoma
  • TAA-specific CTLs
  • Houston, Texas
    Texas Children's Hospital
Jul 14, 2022

B7-H3-positive Relapsed/ Refractory Neuroblastoma Trial in Tianjin (T cell injection targeting FLT3 chimeric antigen receptor)

Not yet recruiting
  • B7-H3-positive Relapsed/ Refractory Neuroblastoma
  • T cell injection targeting FLT3 chimeric antigen receptor
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Nov 1, 2022

Breast Cancer Trial in Houston (TAA-specific CTLs)

Active, not recruiting
Has Results
  • Breast Cancer
  • TAA-specific CTLs
  • Houston, Texas
  • +1 more
May 20, 2022

Rhabdomyosarcoma Trial in Houston (TAA-Specific CTLs)

Completed
  • Rhabdomyosarcoma
  • TAA-Specific CTLs
  • Houston, Texas
  • +1 more
Apr 8, 2022

Acute Myeloid Leukemia Trial in Wuhan (Fludarabine + Cyclophosphamide + TAA05 Cell Injection)

Recruiting
  • Acute Myeloid Leukemia
  • Fludarabine + Cyclophosphamide + TAA05 Cell Injection
  • Wuhan, Hubei, China
    Wuhan Union Hospital
Jun 29, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (MultiTAA-specific T cells)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • MultiTAA-specific T cells
  • Houston, Texas
  • +1 more
May 31, 2022

FLT3-positive Relapsed/Refractory Acute Myeloid Leukemia Trial in Wuhan (T cell injection targeting FLT3 chimeric antigen

Recruiting
  • FLT3-positive Relapsed/Refractory Acute Myeloid Leukemia
  • T cell injection targeting FLT3 chimeric antigen receptor
  • Wuhan, Hubei, China
    Union Hospital, affiliated with TongJi Medical College, HuaZhong
Jun 20, 2022

Neurovegetative Pattern in Thoracic Aortic Aneurysms (TAA)

Recruiting
  • Rare Diseases
  • Aortic Aneurysm, Thoracic
  • Supine resting (REST) and active standing (STAND)
  • San Donato Milanese, Lombardia, Italy
    IRCCS Policlinico San Donato
Jan 19, 2023

Brain Tumor Trial in Washington (TAA-T)

Recruiting
  • Brain Tumor
  • TAA-T
  • Washington, District of Columbia
    Brain Tumor Institute, Children's National Medical Center
Aug 30, 2022

Malignant Melanoma, Lung Cancer, or Colorectal Cancer Trial in Suzhou (TAA06 injection)

Recruiting
  • Malignant Melanoma, Lung Cancer, or Colorectal Cancer
  • TAA06 injection
  • Suzhou, Jiangsu, China
    PersonGen BioTherapeutics(Suzhou) Co., Ltd.
Dec 29, 2021

Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in

Not yet recruiting
  • Head and Neck Cancer
  • +8 more
  • Tumor and HLA Profiling
  • (no location specified)
Mar 31, 2023

Solid Tumor Trial in Washington (Tumor-associated antigen-specific T cell (TAA-T))

Recruiting
  • Solid Tumor
  • Tumor-associated antigen-specific T cell (TAA-T)
  • Washington, District of Columbia
    Children's National Hospital
Oct 24, 2022

CAR, Acute Myeloid Leukemia Trial in Hefei (TAA05 cell injection)

Recruiting
  • CAR
  • Acute Myeloid Leukemia
  • TAA05 cell injection
  • Hefei, Anhui, China
    Anhui Provincial Hospital
Nov 3, 2021

Pancreatic Cancer Trial in Houston (multiTAA specific T cells)

Active, not recruiting
  • Pancreatic Cancer
  • multiTAA specific T cells
  • Houston, Texas
  • +2 more
Feb 7, 2022

Solid Tumors Trial in Washington (Tumor associated antigen lymphocytes (TAA-CTL))

Active, not recruiting
  • Solid Tumors
  • Tumor associated antigen lymphocytes (TAA-CTL)
  • Washington, District of Columbia
    Children's National Medical Center
Jun 1, 2022

Cryoablation of Intercostal Nerves for Better Control of

Not yet recruiting
  • Aneurysm
  • Open thoracic (TAA) and thoracoabdominal aortic aneurysms repair (TAAA)
  • Vienna, Austria
  • +12 more
Aug 2, 2022

Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial in Salt Lake City (TAA-T cells, Nivolumab)

Recruiting
  • Hodgkin Lymphoma
  • Diffuse Large B Cell Lymphoma
  • Salt Lake City, Utah
  • +1 more
Jul 14, 2021

a Descending TAA or PAU Treated With E-nya Thoracic Stent Graft

Recruiting
  • Vascular Aneurysm
  • endovascular repair
  • Münster, NRW, Germany
    Universitätsklinikum Münster
Jul 21, 2021

Leukemia, Lymphoblastic (Acute) Trial in Houston (MultiTAA-specific T cells)

Active, not recruiting
  • Leukemia, Lymphoblastic (Acute)
  • MultiTAA-specific T cells
  • Houston, Texas
  • +1 more
Aug 6, 2021

Overlay of 3D Scans on Live Fluoroscopy for Endovascular

Completed
  • Abdominal Aortic Aneurysm (AAA)
  • +3 more
  • Endovascular Aortic Repair (EVAR)
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Mar 7, 2022

CAR, Acute Myeloid Leukemia Trial in Hefei (Chimeric antigen receptor T cells (car-t))

Recruiting
  • CAR
  • Acute Myeloid Leukemia
  • Chimeric antigen receptor T cells (car-t)
  • Hefei, Anhui, China
    Anhui Provincial Hospital
Mar 4, 2021

Will Permit Sites to Proactively Assess TAA, HLA and HPV-16

Terminated
  • Head and Neck Cancer
  • +7 more
  • Tumor Profiling
  • Scottsdale, Arizona
  • +2 more
Dec 2, 2022

Diastolic Heart Failure, Diastolic Dysfunction Trial in Haifa (CORolla™ TAA device)

Recruiting
  • Diastolic Heart Failure
  • Diastolic Dysfunction
  • CORolla™ TAA device
  • Haifa, Israel
    RAMBAM - Health Care Campus
Oct 7, 2020